JP2023544959A5 - - Google Patents

Info

Publication number
JP2023544959A5
JP2023544959A5 JP2023510390A JP2023510390A JP2023544959A5 JP 2023544959 A5 JP2023544959 A5 JP 2023544959A5 JP 2023510390 A JP2023510390 A JP 2023510390A JP 2023510390 A JP2023510390 A JP 2023510390A JP 2023544959 A5 JP2023544959 A5 JP 2023544959A5
Authority
JP
Japan
Prior art keywords
ham
analog
derivative
seq
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023510390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544959A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/076250 external-priority patent/WO2022063925A1/en
Publication of JP2023544959A publication Critical patent/JP2023544959A/ja
Publication of JP2023544959A5 publication Critical patent/JP2023544959A5/ja
Pending legal-status Critical Current

Links

JP2023510390A 2020-09-24 2021-09-23 改善されたアミリン受容体(hAMY3R)効力を有するhAM15-52類似体 Pending JP2023544959A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20198117 2020-09-24
EP20198117.2 2020-09-24
PCT/EP2021/076250 WO2022063925A1 (en) 2020-09-24 2021-09-23 Ham15-52 analogues with improved amylin receptor (hamy3r) potency

Publications (2)

Publication Number Publication Date
JP2023544959A JP2023544959A (ja) 2023-10-26
JP2023544959A5 true JP2023544959A5 (https=) 2024-09-05

Family

ID=72659001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023510390A Pending JP2023544959A (ja) 2020-09-24 2021-09-23 改善されたアミリン受容体(hAMY3R)効力を有するhAM15-52類似体

Country Status (21)

Country Link
US (2) US12139520B2 (https=)
EP (1) EP4021929B1 (https=)
JP (1) JP2023544959A (https=)
KR (1) KR20230073176A (https=)
CN (1) CN116322741A (https=)
AU (1) AU2021350396A1 (https=)
BR (1) BR112023002525A2 (https=)
CA (1) CA3189267A1 (https=)
DK (1) DK4021929T5 (https=)
ES (1) ES2950137T3 (https=)
FI (1) FI4021929T3 (https=)
HR (1) HRP20230534T1 (https=)
HU (1) HUE062560T2 (https=)
IL (1) IL300620B2 (https=)
MX (1) MX2023002182A (https=)
PL (1) PL4021929T3 (https=)
PT (1) PT4021929T (https=)
RS (1) RS64256B1 (https=)
SI (1) SI4021929T1 (https=)
WO (1) WO2022063925A1 (https=)
ZA (1) ZA202301635B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI815327B (zh) 2021-03-03 2023-09-11 美商美國禮來大藥廠 長效澱粉素受體促效劑及其用途
IL317600B2 (en) 2022-07-01 2026-03-01 Gubra As Amylin receptor (HAMY3R) agonists with improved chemical stability
TW202540155A (zh) 2023-11-30 2025-10-16 丹麥商諾佛 儂迪克股份有限公司 Glp-1、gip及澱粉素受體之三重促效劑

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
GB9912350D0 (en) * 1999-05-26 1999-07-28 European Molecular Biology Lab Embl Modified cytokine
FI117667B (fi) * 2001-07-05 2007-01-15 Univ Zuerich Farmaseuttinen koostumus, joka soveltuu käytettäväksi ortopediassa ja hammaslääketieteessä
NZ579621A (en) * 2004-02-11 2011-03-31 Amylin Pharmaceuticals Inc Hybrid polypeptides with selectable properties
WO2007022123A2 (en) 2005-08-11 2007-02-22 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
AU2012212047A1 (en) * 2011-02-03 2013-08-22 Xoma Technology Ltd. Methods and materials for enhancing functional protein expression in bacteria
JP6121992B2 (ja) 2011-06-10 2017-04-26 ノヴォ ノルディスク アー/エス ポリペプチド
AR097701A1 (es) * 2013-09-19 2016-04-13 Zealand Pharma As Análogos de amilina
BR112017019378A2 (pt) 2015-03-18 2019-02-19 Zealand Pharma A/S análogos de amilina
WO2019005623A1 (en) 2017-06-30 2019-01-03 Adepthera Llc PEPTIDE ANALOGS
AR116632A1 (es) 2018-10-11 2021-05-26 Intarcia Therapeutics Inc Polipéptidos análogos de la amilina humana y sus métodos de uso

Similar Documents

Publication Publication Date Title
JP2023544959A5 (https=)
JP6199797B2 (ja) 環状抗微生物ペプチド
JP5907970B2 (ja) インターロイキン−22のウイルス性肝炎の治療における応用
US9518093B2 (en) Topical formulation of arginine-rich cyclic antimicrobial peptides
JP2023534131A5 (https=)
JP2011518179A5 (https=)
JP2007531715A (ja) グリコール結合fgf−21化合物
JP2005537234A5 (https=)
JP2023166406A5 (https=)
JP2008507298A5 (https=)
JP2011001381A (ja) Glp−1医薬組成物
WO2013036973A2 (en) Methods and compositions for controlling assembly of viral proteins
JP2004531242A5 (https=)
JP2006502702A5 (https=)
JP2020117504A5 (https=)
EP4268895A3 (en) Uses of cyp4v2 and rdcvf in preparation of drugs
SK26493A3 (en) Aprotinin analogues
JP2024525213A5 (https=)
JP2005512518A5 (https=)
CN110769843A (zh) C5a受体激动剂肽的盐酸盐
CN101389642B (zh) 环状抗微生物肽
JP2000505791A (ja) 肥満症タンパク質類似体化合物およびその製剤
CN107847452A (zh) 应答选择性C5a激动剂EP67的构象稳定类似物
JP2021518392A5 (https=)
CN115698036B (zh) 新型抗炎肽及其用途